Yingchang Guo

机构：First Affiliated Hospital of Xinxiang Medical University, Henan Medical University

发表论文 16 篇 · 总被引 172 次 · h-index 9

代表论文

• Peptide encoded by lncRNA BVES-AS1 promotes cell viability, migration, and invasion in colorectal cancer cells via the SRC/mTOR signaling pathway (2023 · PLoS ONE · 被引 30)
• lncRNA TTN‑AS1 upregulates RUNX1 to enhance glioma progression via sponging miR‑27b‑3p (2020 · Oncology Reports · 被引 22)
• Down-regulation of Rab17 promotes tumourigenic properties of hepatocellular carcinoma cells via Erk pathway. (2015 · PubMed · 被引 16)
• RNA interference targeting adrenomedullin induces apoptosis and reduces the growth of human bladder urothelial cell carcinoma (2013 · Medical Oncology · 被引 15)
• Exploring the anticancer effects of tin oxide nanoparticles synthesized by pulsed laser ablation technique against breast cancer cell line through downregulation of PI3K/AKT/mTOR signaling pathway (2021 · Arabian Journal of Chemistry · 被引 13)
• Endovascular Thrombectomy VS. Medical Treatment for Mild Stroke Patients: A Systematic Review and Meta-Analysis (2020 · Journal of Stroke and Cerebrovascular Diseases · 被引 13)